Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-ONRC-13003571Phase 4Completed
Phase 4, open-label trial of danhong injection (4 arms), sponsored by Shanghai Institute of Materia Medica. Primary endpoints: Plasma drug concentration, Urinary drug concentration and 5 more. Started Sep 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-ONRC-13003571.